Alinity i Total ß-hCG Reagent Kit, Alinity i System
by Abbott Laboratories 510(k)
Active
510(k) K170317
Regulatory status
Recall ongoing. 2 ongoing FDA recalls. See recalls
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK170317 | Date23 Oct 2017 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
-
- Ongoing Z-0961-2026
Abbott Laboratories is recalling their Alinity ci-series System Control Module, a chemistry/immunoassay anayzer, by correction. The reason for the recall is potential performance issues found in the Alinity ci-series System software versions 3.6.1. and lower that could lead to erroneous results for multiple analytes. The issue was identified by Abbott during the internal testing of complaint investigations.
-
- Ongoing Z-0958-2023
Reaction vessels may contain a potential contaminant that could affect their optical performance.
-
- Terminated Z-0666-2019
Abbott has become aware of a manufacturing issue that can result in damage to a bottle neck in some of the reagent cartridges found in the lots listed in Appendix A. If a bottle neck is damaged, it may cause a failure during the reagent loading process on the Alinity i instrument.
Specification
- 510(k) Number
- FDA Product Code
- DHA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1155
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent